Abstract
Background
Heart rate variability (HRV) reduction is a potential biomarker for sudden cardiac death. This study aimed to study the effects of anti-seizure medications (ASMs), adjusted with reported factors associated with sudden unexpected death in epilepsy (SUDEP) on HRV parameters.
Methods
We recruited patients who were admitted in our epilepsy monitoring unit between January 2013 and December 2021. Two 5-min electrocardiogram epochs during wakefulness and sleep were selected in each patient. HRV analysis with Python® software was performed. The imputed datasets were used for linear regression analysis to assess association between each ASM item and all HRV parameters. The effects of ASM on HRV parameters were subsequently adjusted with the significant clinical characteristics and the concomitant use of other ASMs, respectively.
Results
Carbamazepine (CBZ), levetiracetam (LEV), lamotrigine (LTG), and clonazepam (CZP) were statistically significantly associated with changes of sleep HRV parameters. Only CBZ showed negative effects with reduction in HRV, evidenced as lower standard deviation of RR interval (SDNN), even when adjusted with concomitant use of other ASMs (p = 0.045) and had a trend of significance when adjusted with significant clinical characteristics of concurrent taking of beta-blocker drug (p = 0.052). LEV and CZP showed opposite effects with increased HRV even when adjusted with significant clinical characteristics and the concomitant use of other ASMs.
Conclusions
CBZ showed negative effects on HRV. We proposed that CBZ should be cautiously used in patients with known risks for SUDEP. In addition, HRV assessment should be performed prior to commencing CBZ and re-performed in follow-up in cases of prolonged use.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Ansakorpi H, Korpelainen JT, Suominen K, Tolonen U, Myllylä VV, Isojärvi JI (2000) Interictal cardiovascular autonomic responses in patients with temporal lobe epilepsy. Epilepsia 41(1):42–47. https://doi.org/10.1111/j.1528-1157.2000.tb01503.x
Aurlien D, Taubøll E, Gjerstad L (2007) Lamotrigine in idiopathic epilepsy - increased risk of cardiac death? Acta Neurol Scand 115(3):199–203. https://doi.org/10.1111/j.1600-0404.2006.00730.x
Clancy MJ, Clarke MC, Connor DJ, Cannon M, Cotter DR (2014) The prevalence of psychosis in epilepsy; a systematic review and meta-analysis. BMC Psychiatry 14:75. https://doi.org/10.1186/1471-244x-14-75
DeGiorgio CM, Curtis A, Hertling D, Moseley BD (2019) Sudden unexpected death in epilepsy: risk factors, biomarkers, and prevention. Acta Neurol Scand 139(3):220–230. https://doi.org/10.1111/ane.13049
Druschky A, Hilz MJ, Hopp P, Platsch G, Radespiel-Tröger M, Druschky K, Kuwert T, Stefan H, Neundörfer B (2001) Interictal cardiac autonomic dysfunction in temporal lobe epilepsy demonstrated by [(123)I]metaiodobenzylguanidine-SPECT. Brain 124(Pt 12):2372–2382. https://doi.org/10.1093/brain/124.12.2372
Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J, Pringsheim T, Lorenzetti DL, Jetté N (2017) Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology 88(3):296–303. https://doi.org/10.1212/wnl.0000000000003509
Gaitatzis A, Carroll K, Majeed A, Sander JW (2004) The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 45(12):1613–1622. https://doi.org/10.1111/j.0013-9580.2004.17504.x
GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 May;18(5):459–480
Graham JW (2009) Missing data analysis: making it work in the real world. Annu Rev Psychol 60:549–576. https://doi.org/10.1146/annurev.psych.58.110405.085530
Graham JW, Olchowski AE, Gilreath TD (2007) How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci 8(3):206–213. https://doi.org/10.1007/s11121-007-0070-9
Hallioglu O, Okuyaz C, Mert E, Makharoblidze K (2008) Effects of antiepileptic drug therapy on heart rate variability in children with epilepsy. Epilepsy Res 79(1):49–54. https://doi.org/10.1016/j.eplepsyres.2007.12.020
Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996 Mar;17(3):354–81
Hesdorffer DC, Tomson T, Benn E, Sander JW, Nilsson L, Langan Y, Walczak TS, Beghi E, Brodie MJ, Hauser A (2011) Combined analysis of risk factors for SUDEP. Epilepsia 52(6):1150–1159. https://doi.org/10.1111/j.1528-1167.2010.02952.x
Hesdorffer DC, Tomson T, Benn E, Sander JW, Nilsson L, Langan Y, Walczak TS, Beghi E, Brodie MJ, Hauser WA (2012) Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. Epilepsia 53(2):249–252. https://doi.org/10.1111/j.1528-1167.2011.03354.x
Isojärvi JI, Ansakorpi H, Suominen K, Tolonen U, Repo M, Myllylä VV (1998) Interictal cardiovascular autonomic responses in patients with epilepsy. Epilepsia 39(4):420–426. https://doi.org/10.1111/j.1528-1157.1998.tb01394.x
Jain S, Nair PP, Aghoram R, Wadwekar V, Wagh S, Balachandran M, Indira Priya D, Meher R, Nandwani S, Sreekumaran Nair N (2021) Interictal autonomic changes in persons with epilepsy (PWE) on carbamazepine (CBZ) versus other anti-seizure drug monotherapy: a cross-sectional study. Epilepsy Behav 125:108396. https://doi.org/10.1016/j.yebeh.2021.108396
Jiang W, Ladd S, Martsberger C, Feinglos M, Spratt SE, Kuchibhatla M, Green J, Krishnan R (2011) Effects of pregabalin on heart rate variability in patients with painful diabetic neuropathy. J Clin Psychopharmacol 31(2):207–213. https://doi.org/10.1097/JCP.0b013e31820f4f57
Keezer MR, Sisodiya SM, Sander JW (2016) Comorbidities of epilepsy: current concepts and future perspectives. Lancet Neurol 15(1):106–115. https://doi.org/10.1016/s1474-4422(15)00225-2
Kennebäck G, Ericson M, Tomson T, Bergfeldt L (1997) Changes in arrhythmia profile and heart rate variability during abrupt withdrawal of antiepileptic drugs. Implications for sudden death. Seizure 6(5):369–375. https://doi.org/10.1016/s1059-1311(97)80036-2
Lathers CM, Schraeder PL (1982) Autonomic dysfunction in epilepsy: characterization of autonomic cardiac neural discharge associated with pentylenetetrazol-induced epileptogenic activity. Epilepsia 23(6):633–647. https://doi.org/10.1111/j.1528-1157.1982.tb05079.x
Levira F, Thurman DJ, Sander JW, Hauser WA, Hesdorffer DC, Masanja H, Odermatt P, Logroscino G, Newton CR (2017) Premature mortality of epilepsy in low- and middle-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia 58(1):6–16. https://doi.org/10.1111/epi.13603
Lotufo PA, Valiengo L, Benseñor IM, Brunoni AR (2012) A systematic review and meta-analysis of heart rate variability in epilepsy and antiepileptic drugs. Epilepsia 53(2):272–282. https://doi.org/10.1111/j.1528-1167.2011.03361.x
Moss G, Stein AA (1975) Cerebral etiology of the acute respiratory distress syndrome: diphenylhydantoin prophylaxis. J Trauma 15(1):39–41. https://doi.org/10.1097/00005373-197501000-00007
Myers KA, Sivathamboo S, Perucca P (2018) Heart rate variability measurement in epilepsy: how can we move from research to clinical practice? Epilepsia 59(12):2169–2178. https://doi.org/10.1111/epi.14587
Nilsson L, Farahmand BY, Persson PG, Thiblin I, Tomson T (1999) Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet 353(9156):888–893. https://doi.org/10.1016/s0140-6736(98)05114-9
Persson H, Ericson M, Tomson T (2003) Carbamazepine affects autonomic cardiac control in patients with newly diagnosed epilepsy. Epilepsy Res 57(1):69–75. https://doi.org/10.1016/j.eplepsyres.2003.10.012
Sathyaprabha TN, Koot LAM, Hermans BHM, Adoor M, Sinha S, Kramer BW, Raju TR, Satishchandra P, Delhaas T (2018) Effects of chronic carbamazepine treatment on the ECG in patients with focal seizures. Clin Drug Investig 38(9):845–851. https://doi.org/10.1007/s40261-018-0677-6
Schafer JL (1999) Multiple imputation: a primer. Stat Methods Med Res 8(1):3–15. https://doi.org/10.1177/096228029900800102
Sessa F, Anna V, Messina G, Cibelli G, Monda V, Marsala G, Ruberto M, Biondi A, Cascio O, Bertozzi G, Pisanelli D, Maglietta F, Messina A, Mollica MP, Salerno M (2018) Heart rate variability as predictive factor for sudden cardiac death. Aging (Albany NY) 10(2):166–177. https://doi.org/10.18632/aging.101386
Shaffer F, Ginsberg JP (2017) An overview of heart rate variability metrics and norms. Frontiers in Public Health 5:258. https://doi.org/10.3389/fpubh.2017.00258
Shankar R, Donner EJ, McLean B, Nashef L, Tomson T (2017) Sudden unexpected death in epilepsy (SUDEP): what every neurologist should know. Epileptic Disord 19(1):1–9. https://doi.org/10.1684/epd.2017.0891
Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. Bmj 338:b2393. https://doi.org/10.1136/bmj.b2393
Sveinsson O, Andersson T, Carlsson S, Tomson T (2017) The incidence of SUDEP: a nationwide population-based cohort study. Neurology 89(2):170–177. https://doi.org/10.1212/wnl.0000000000004094
Téllez-Zenteno JF, Matijevic S, Wiebe S (2005) Somatic comorbidity of epilepsy in the general population in Canada. Epilepsia 46(12):1955–1962. https://doi.org/10.1111/j.1528-1167.2005.00344.x
Thurman DJ, Logroscino G, Beghi E, Hauser WA, Hesdorffer DC, Newton CR, Scorza FA, Sander JW, Tomson T (2017) The burden of premature mortality of epilepsy in high-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia 58(1):17–26. https://doi.org/10.1111/epi.13604
Timmings PL (1998) Sudden unexpected death in epilepsy: is carbamazepine implicated? Seizure 7(4):289–291. https://doi.org/10.1016/s1059-1311(98)80020-4
Tomson T, Kennebäck G (1997) Arrhythmia, heart rate variability, and antiepileptic drugs. Epilepsia 38(11 Suppl):S48-51. https://doi.org/10.1111/j.1528-1157.1997.tb06128.x
Acknowledgements
We wish to thank Veera Saidoung for helping with HRV analysis and EEG database management.
Author information
Authors and Affiliations
Contributions
Danist Leosuthamas: Carried out data acquisition, drafted the manuscript, gave final approval, and agreed to be accountable for all aspects of work ensuring integrity and accuracy. Chusak Limotai: Designed the study, carried out data acquisition and data analysis, drafted the manuscript, critically revised the manuscript, gave final approval, and agreed to be accountable for all aspects of work ensuring integrity and accuracy. Nattawut Unwanatham: Carried out data analysis, gave final approval, and agreed to be accountable for all aspects of work ensuring integrity and accuracy. Sasivimol Rattanasiri: Carried out data analysis, gave final approval, and agreed to be accountable for all aspects of work ensuring integrity and accuracy.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflict of interest.
Ethical approval
The study was approved by the Institutional Review Board of Faculty of Medicine, Chulalongkorn University.
Informed consent
Informed consent was waived because of the retrospective nature of the study and the analysis used anonymous clinical data.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Highlights
• Reductions in HRV were found in epilepsy subgroups at high risk for SUDEP, i.e., chronic TLE and Dravet’s syndrome.
• Controversy still surrounds whether or not ASMs are related to SUDEP.
• In our study population, i.e., drug-resistant focal epilepsy mainly TLE, negative effect of CBZ, and reduction in HRV was demonstrated.
• CBZ should be cautiously used in patients with known risks for SUDEP.
• HRV assessment should be performed prior to commencing CBZ and re-performed in follow-up in cases of prolonged use.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Leosuthamas, D., Limotai, C., Unwanatham, N. et al. Is anti-seizure medication the culprit of SUDEP?. Neurol Sci 44, 3659–3668 (2023). https://doi.org/10.1007/s10072-023-06871-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-023-06871-0